Diabetes Guidelines in Practice- Clinical case 1

This video makes reference to guidelines produced by the "National Institute for Health and Care Excellence" in the UK, also referred to as "NICE". Please note that the content on this channel reflects my professional interpretation/summary of the guidance and that I am in no way affiliated with, employed by or funded/sponsored by NICE.

My name is Fernando Florido and I am a GP in the United Kingdom. With this episode I am starting a new series on Diabetes Guidelines in Practice, looking at how the guidelines could apply to randomly selected clinical cases. By way of disclaimer, I am not giving medical advice; this video is intended for health care professionals, remember that guidelines are there to be interpreted and applied using your clinical judgement. What I am doing here is sharing with you what my interpretation would be in this case. It does not mean that it is the only way, or indeed the best way to treat any individual patient.

Tracks:

00:00 – Introduction, welcome and disclaimer
01:13 – Random case selection
02:18 – Choosing drug treatment
08:43 – Conclusion, thank you and good-bye

There is a podcast version of this and other videos that you can access here:

Diabetes in Primary Care podcast:

Primary Care guidelines podcast:

[ojushealthcare]

This is a fantastic format, doctor! Much more easily understood and retained than A to Z of diabetes. Thanks again!

[carljenkins]

Would welcome more of these. Thanks for uploading.

[ReshmiNair-qw]

Hi Dr., I have a doubt, we normally dont initiate SGLT2 inhibitors for diabetes when the egfr is below 60 and doesnt the SGLT2 inhibitors antidiabetic effect lower when the egfr is below 45? Looking forward for your reply. Many thanks.